The Strangest Feeling: Temporal Lobe Epilepsy (TLE)

The team at Cortechs.ai is always looking to further educate ourselves about how brain volumetric imaging is used in the assessment of neurodegenerative conditions. Recently, a practicing Clinical Neuropsychologist visited our San Diego headquarters and gave a very interesting presentation about Temporal Lobe Epilepsy (TLE), its treatments, and how volumetric MRI is involved in the diagnosis.

Seizures are common, and having a single seizure does not mean a person has epilepsy. 4% of the population will have a single seizure at some point in their lifetime. Epilepsy occurs when someone has multiple recurring and unprovoked seizures. 2.2 million people are living with epilepsy in the U.S., and about 150,000 are newly diagnosed per year.

Cortechs.ai | The Strangest Feeling: Temporal Lobe Epilepsy (TLE)
image credit: Epilepsy Foundation

Of the various forms of epilepsy, Temporal Lobe Epilepsy (TLE) is the most common (65% of all cases). For 20-30% of people living with TLE, anti-seizure medications do not work. Physicians and researchers haven’t yet pinpointed what causes TLE. They do know, however, that certain aspects might lead to epilepsy in the future, such as a history of febrile convulsions under the age of 5 and a family history of epilepsy. Early intervention can improve the quality of life for people with TLE. Surgery can be an effective treatment option, especially for those where the source of the seizures is clear and where the medicines don’t control the seizures.

TLE is localized in the temporal lobe of one side of the brain with the hippocampus being the most common structure affected. Diagnosis of TLE is made using an electroencephalogram (EEG), which detects electrical activity in the brain using electrodes attached to the scalp. A MRI scan of the brain is typically performed, to give physicians better visualization on the brain and help determine which structure on which side of the brain may have structural damage, and thus could be the source of the seizures.

NeuroQuant® is a leading medical device software that is used in post-processing of the MRI scan. It maps the sub-cortical brain structures and provides their volumetric imaging. NeuroQuant uses the images from the MRI scan to measure the volume of certain brain structures and the asymmetry between them, in this case the left and right hippocampi, providing important information in the assessment of temporal lobe epilepsy. For TLE, the NeuroQuant Hippocampal Volume Asymmetry Report can be used to help assess which side of the hippocampus may have damage and thus could be causing the seizures, especially in subtle instances.

 

  1. Farid, Nikdokht et al. (2012). Temporal Lobe Epilepsy: Quantitative MR Volumetry in Detection of Hippocampal Atrophy. Radiology: 264(2).
  2. http://www.epilepsy.com/learn/types-epilepsy-syndromes/temporal-lobe-epilepsy
  3. http://www.radiologyassistant.nl/en/p4f53597deae16/role-of-mri-in-epilepsy.html

More Resources

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression
Scroll to Top